| CAS |
No.183133-96-2 |
| 中文名称 |
卡巴他赛(10mM in DMSO,无菌） |
| 英文名称 |
Cabazitaxel(10mM in DMSO，Sterile） |
| 分子式 |
C45H57NO14 |
| 分子量 |
835.93 |
| 溶解性 |
请根据自己的实验要求使用。 |
| 外观(性状) |
无菌溶液 |
| 储存条件 |
Stroe at -20℃，6 months. |
| 靶点 |
Microtubule/Tubulin |
| 通路 |
Cytoskeleton |
| 背景说明 |
Cabazitaxel 具有显著的抗肿瘤活性。 |
| 生物活性 |
Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.[1-2] |
| In Vitro |
The cytotoxicity of cabazitaxel (100 μg/mL) on 4T1 cells without irradiation is 70.8%. Cabazitaxel (100 μg/mL) exhibits a concentration-dependent antiproliferation effect， with the antiproliferative activity of 56.2%[1]. |
| In Vivo |
Cabazitaxel (10 mg/kg， i.v.) has certain toxicity to liver and kidney but it can be avoided by integrated into Ans. The body weights of mice treated with AN-ICG-CBX and AN-CBX have a slightly decrease， while body weights of the free CBX group significantly decrease compared to the control group[1]. |
| 细胞实验 |
The cytotoxicity of CBX-loaded ANs and free Cabazitaxel (CBX) is evaluated with MTT assay. Cells are seeded onto a 96-well plate at a density of 3000 cells per well and cultured for 24 h. CBX-loaded ANs and free CBX are diluted to predetermined concentrations with PBS and added into each well. Blank AN， AN-ICG and free CBX solvent (a mixture of Tween-80 and anhydrous alcohol) are added as well to different final concentrations. The incubation continued for another 48 hours. 20 μL MTT solutions (5 mg/mL in PBS) are added into each well and cells are incubated for another 4 hours under 37°C. Subsequently the medium is removed and 150 μL dimethyl sulphoxide (DMSO) is added to dissolve the purple formazan salt crystals. Then the absorbance is measured by a microplate reader at 490 nm. The cells treated with medium are evaluated as controls. |
| 动物实验 |
To evaluate the antitumor efficiency of the combined chemotherapy and PTT in vivo， mice bearing 4T1 tumor are randomLy divided into 6 treatment groups (n=5). Treatment begin when the tumors reached 50 mm3-100 mm3. The mice are intravenously injected with saline， AN-ICG， free Cabazitaxel (CBX)， AN-CBX and AN-ICG-CBX (ICG 2 mg/kg， CBX 10 mg/kg). 8 hours later， the groups injected with AN-ICG and AN-ICG-CBX is irradiated by the 808 nm laser (0.8 W/cm2， 5 min). The length and width of every tumor are measured by a caliper every other day. The formula (volume (mm3) =1/2 × length × width2) is used to calculate the tumor volume. The body weights of these mice are recorded every two days using an electronic balance as well. At the end of the antitumor study， the 4T1 tumor bearing mice are sacrificed to collect the tumors and major organs. |
| 数据来源文献 |
[1]. Tai X， et al. Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity. J Drug Target. 2016 Sep 9:1-29.
[2]. Gdowski AS， et al. Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain. Nanomedicine (Lond). 2017 Sep;12(17):2083-2095. |
| 规格 |
1ml |
| 单位 |
瓶 |
中文
英语
说明书下载
京公网安备 11011202000391号